Cho Esther
Keros Therapeutics, Inc. · SVP
Cho Esther is listed in filings as SVP at Keros Therapeutics, Inc.. This profile follows SEC Form 4 activity through Mar 27, 2026, including sale activity. Recent filings connect the profile to Keros Therapeutics, Inc. (KROS). The current snapshot covers public activity from Feb 20, 2026 to Mar 27, 2026. Reported amounts are shown as $77.6K to $1.2M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $78k4.7k shares | SellFeb 18, 2026 | $16.35 | $10.61 |